reglab/housing_qa huggingface dataset:
MD. Health - General Code Ann. §  13-3311.1 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission|Section 13-3311.1 - Sale or Transfer of Ownership in License; Rescission of Stage One Preapproval; Exceptions

    (a)    (1)    The holder of a medical cannabis grower, processor, or dispensary license may sell or transfer ownership of the license if the licensee was physically and actively engaged in the cultivation, processing, or dispensing of medical cannabis for at least 3 years immediately preceding the sale or transfer of the ownership of the license.        (2)    Nothing in paragraph (1) of this subsection may be construed to limit the ability of the Commission to enforce this subtitle.    (b)    (1)    Subject to paragraph (2) of this subsection, the Commission may rescind the Stage One preapproval of an applicant if the facility of the applicant is not operational within 12 months after issuance of the Stage One preapproval due to a lack of a good faith effort by the applicant to become operational.        (2)    If the applicant can demonstrate to the Commission that the failure to become operational under paragraph (1) of this subsection was due to unforeseen hardship beyond the control of the applicant, the Commission may extend the time frame to become operational for an additional 12 months before rescinding the Stage One preapproval.
MD. Health - General Code Ann. §  13-3312 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission|Section 13-3312 - Criminal History Check of Applicants

    (a)    In this section, “Central Repository” means the Criminal Justice Information System Central Repository of the Department of Public Safety and Correctional Services.    (b)    As part of an application to the Central Repository for a State and national criminal history records check, an applicant shall submit to the Central Repository:        (1)    Two complete sets of legible fingerprints taken on forms approved by the Director of the Central Repository and the Director of the Federal Bureau of Investigation;        (2)    The fee authorized under § 10–221(b)(7) of the Criminal Procedure Article for access to State criminal history records; and        (3)    The processing fee required by the Federal Bureau of Investigation for a national criminal history records check.    (c)    In accordance with §§ 10–201 through 10–228 of the Criminal Procedure Article, the Central Repository shall forward to the Commission and to the applicant the criminal history record information of the applicant.    (d)    If an applicant has made two or more unsuccessful attempts at securing legible fingerprints, the Commission may accept an alternate method of a criminal history records check as permitted by the Director of the Central Repository and the Director of the Federal Bureau of Investigation.    (e)    Information obtained from the Central Repository under this section shall be:        (1)    Confidential and may not be redisseminated; and        (2)    Used only for the registration purpose authorized by this subtitle.    (f)    The subject of a criminal history records check under this section may contest the contents of the printed statement issued by the Central Repository, as provided in § 10–223 of the Criminal Procedure Article.
MD. Health - General Code Ann. §  13-3313 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission|Section 13-3313 - Exemption From Arrest, Prosecution, Revocation of Supervision, Parole, or Probation, or Any Civil or Administrative Penalty; Penalty for Distributing, Possessing, Manufacturing, or Using Cannabis Diverted From Approved Program

    (a)    Any of the following persons acting in accordance with the provisions of this subtitle may not be subject to arrest, prosecution, revocation of mandatory supervision, parole, or probation, or any civil or administrative penalty, including a civil penalty or disciplinary action by a professional licensing board, or be denied any right or privilege, for the medical use of or possession of medical cannabis:        (1)    A qualifying patient:            (i)    In possession of an amount of medical cannabis determined by the Commission to constitute a 30–day supply; or            (ii)    In possession of an amount of medical cannabis that is greater than a 30–day supply if the qualifying patient’s certifying provider stated in the written certification that a 30–day supply would be inadequate to meet the medical needs of the qualifying patient;        (2)    A grower licensed under § 13–3306 of this subtitle or a grower agent registered under § 13–3306 of this subtitle;        (3)    A certifying provider;        (4)    A caregiver;        (5)    An academic research representative purchasing medical cannabis under § 13–3304.1 of this subtitle;        (6)    A dispensary licensed under § 13–3307 of this subtitle or a dispensary agent registered under § 13–3308 of this subtitle;        (7)    A processor licensed under § 13–3309 of this subtitle or a processor agent registered under § 13–3310 of this subtitle;        (8)    A hospital, medical facility, or hospice program where a qualifying patient is receiving treatment;        (9)    A third–party vendor authorized by the Commission to test, transport, or dispose of medical cannabis, medical cannabis products, or medical cannabis waste under the provisions of this subtitle; or        (10)    Designated school personnel authorized to administer medical cannabis to a student in accordance with the guidelines established under § 7–446 of the Education Article unless the act or omission constitutes gross negligence or wanton or willful misconduct.    (b)    (1)    A person may not distribute, possess, manufacture, or use cannabis that has been diverted from a qualifying patient, a caregiver, an academic research representative, a licensed grower, or a licensed dispensary.        (2)    A person who violates this subsection is guilty of a felony and on conviction is subject to imprisonment not exceeding 5 years or a fine not exceeding $10,000 or both.        (3)    The penalty under this subsection is in addition to any penalties that a person may be subject to for manufacture, possession, or distribution of marijuana under the Criminal Law Article.
MD. Health - General Code Ann. §  13-3314 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission|Section 13-3314 - Construction of Subtitle

    (a)    This subtitle may not be construed to authorize any individual to engage in, and does not prevent the imposition of any civil, criminal, or other penalties for, the following:        (1)    Undertaking any task under the influence of marijuana or cannabis, when doing so would constitute negligence or professional malpractice;        (2)    Operating, navigating, or being in actual physical control of any motor vehicle, aircraft, or boat while under the influence of marijuana or cannabis;        (3)    Smoking marijuana or cannabis in any public place;        (4)    Smoking marijuana or cannabis in a motor vehicle; or        (5)    Except as provided in subsection (b) of this section, smoking marijuana or cannabis on a private property that:            (i)    1.    Is rented from a landlord; and                2.    Is subject to a policy that prohibits the smoking of marijuana or cannabis on the property; or            (ii)    Is subject to a policy that prohibits the smoking of marijuana or cannabis on the property of an attached dwelling adopted by one of the following entities:                1.    The board of directors of the council of unit owners of a condominium regime; or                2.    The governing body of a homeowners association.    (b)    The provisions of subsection (a)(5) of this section do not apply to vaporizing cannabis.    (c)    This subtitle may not be construed to provide immunity to a person who violates the provisions of this subtitle from criminal prosecution for a violation of any law prohibiting or regulating the use, possession, dispensing, distribution, or promotion of controlled dangerous substances, dangerous drugs, detrimental drugs, or harmful drugs, or any conspiracy or attempt to commit any of those offenses.    (d)    This subtitle may not be construed to require a hospital, medical facility, or hospice program to report to the Commission any disciplinary action taken by the hospital, medical facility, or hospice program against a certifying provider, including the revocation of privileges, after the registration of the certifying provider by the Commission.    (e)    This subtitle may not be construed to prohibit a person from being concurrently licensed by the Commission as a grower, a dispensary, or a processor.
MD. Health - General Code Ann. §  13-3315 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission|Section 13-3315 - Federal Investigations or Prosecutions

    (a)    Notwithstanding § 12–315 of the State Government Article, a State employee who incurs counsel fees in connection with a federal criminal investigation or prosecution solely related to the employee’s good faith discharge of public responsibilities under this subtitle is eligible for reimbursement of counsel fees as authorized by § 12–314 of the State Government Article.    (b)    The Governor may suspend implementation of this subtitle on making a determination that there is a reasonable chance of federal prosecution of State employees for involvement with implementation of this subtitle.
MD. Health - General Code Ann. §  13-3316 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission|Section 13-3316 - Regulations

    The Commission shall adopt regulations to implement the provisions of this subtitle.
MD. Health - General Code Ann. §  13-3401 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 34 - Family Planning Program|Section 13-3401 - Definitions

    (a)    In this subtitle the following words have the meanings indicated.    (b)    “Family planning providers” means providers of services:        (1)    Funded under Title X of the federal Public Health Service Act as of December 31, 2016; and        (2)    That lost eligibility for Title X funding as a result of the termination of federal funding for providers because of:            (i)    The scope of services offered by the providers; or            (ii)    The scope of services for which the providers offer referrals.    (c)    “Family planning services” means services provided under Title X of the federal Public Health Service Act as of December 31, 2016.    (d)    “Program” means the Family Planning Program established under § 13–3402 of this subtitle.
MD. Health - General Code Ann. §  13-3402 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 34 - Family Planning Program|Section 13-3402 - General Consideration

    (a)    There is a Family Planning Program in the Department.    (b)    The purpose of the Program is to ensure the continuity of family planning services in the State.    (c)    The Program shall provide family planning services to individuals who are eligible for family planning services through family planning providers that meet Program requirements.    (d)    The Department may adopt regulations to implement this subtitle, including regulations establishing a sliding scale fee for services provided under the Program.    (e)    Funding used to support family planning services under the Program shall be in addition to any funding applied by the Department before December 31, 2016, to the maintenance of effort requirement for federal funding under Title X of the federal Public Health Service Act.    (f)    (1)    The Department may not accept any federal funding under Title X of the federal Public Health Service Act if the Title X program:            (i)    Excludes family planning providers; and            (ii)    Does not require family planning providers to provide a broad range of acceptable and effective medically approved family planning methods and services.        (2)    If the Department does not accept Title X program funds in accordance with paragraph (1) of this subsection, the Governor shall fund the Program with State funds at the same level of total funds provided to the Program in the immediately preceding fiscal year.
MD. Health - General Code Ann. §  13-3501 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 35 - Co-Prescribing of Opioid Overdose Reversal Drugs|Section 13-3501 - Definitions

    (a)    In this subtitle the following words have the meanings indicated.    (b)    “Co–prescribing” means, with respect to an opioid overdose reversal drug, the practice of prescribing the drug in conjunction with an opioid prescription for a patient at an elevated risk of overdose.    (c)    “Opioid overdose reversal drug” means naloxone or a similarly acting and equally safe drug that is approved by the federal Food and Drug Administration for the treatment of a known or suspected opioid overdose.
MD. Health - General Code Ann. §  13-3502 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 35 - Co-Prescribing of Opioid Overdose Reversal Drugs|Section 13-3502 - Establishment of Guidelines for Co-Providing Opioid Overdose Reversal Drugs

    (a)    The Secretary shall establish guidelines for the co–prescribing of opioid overdose reversal drugs that are applicable to all licensed health care providers in the State who are authorized by law to prescribe a monitored prescription drug, as defined in § 21–2A–01 of this article.    (b)    The guidelines established under subsection (a) of this section shall address the co–prescribing of opioid overdose reversal drugs for patients who are:        (1)    At an elevated risk of overdose; and        (2)    (i)    Receiving opioid therapy for chronic pain;            (ii)    Receiving a prescription for benzodiazepines; or            (iii)    Being treated for opioid use disorders.
MD. Health - General Code Ann. §  13-3601 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 36 - Reporting of Overdoses|Section 13-3601 - Definitions

    (a)    In this subtitle the following words have the meanings indicated.    (b)    “Emergency medical services provider” has the meaning stated in § 13–516 of the Education Article.    (c)    “Law enforcement officer” has the meaning stated in § 3–101 of the Public Safety Article.    (d)    “Overdose” means a condition, including extreme physical illness, decreased level of consciousness, respiratory depression, coma, or death, resulting from the consumption or use of any controlled dangerous substance that requires medical attention, assistance, or treatment, and clinical suspicion for drug overdose, including respiratory depression, unconsciousness, or altered mental state, without other conditions to explain the clinical condition.
MD. Health - General Code Ann. §  13-3602 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 36 - Reporting of Overdoses|Section 13-3602 - Reporting of Overdose by Emergency Medical Services Provider or Law Enforcement Officer

    (a)    An emergency medical services provider or a law enforcement officer who treats and releases or transports to a medical facility an individual experiencing a suspected or an actual overdose may report the incident using an appropriate information technology platform with secure access, including the Washington/Baltimore High Intensity Drug Trafficking Area overdose detection mapping application program, or any other program operated by the federal government or a unit of State or local government.    (b)    A report of an overdose made under this section shall include:        (1)    The date and time of the overdose;        (2)    The approximate address where the overdose victim was initially encountered or where the overdose occurred;        (3)    Whether an opioid overdose reversal drug was administered; and        (4)    Whether the overdose was fatal or nonfatal.    (c)    If an emergency medical services provider or a law enforcement officer reports an overdose under this section, the emergency medical services provider or law enforcement officer making the report shall make best efforts to make the report within 24 hours after responding to the incident.    (d)    On receipt of a patient care report that indicates an overdose, the Maryland Institute for Emergency Medical Services Systems shall report the information listed under subsection (b) of this section to an appropriate information technology platform with secure access, including the Washington/Baltimore High Intensity Drug Trafficking Area overdose detection mapping application, or any other program operated by the federal government or a unit of State or local government.    (e)    Overdose information reported by an emergency medical services provider under subsection (a) of this section or by the Maryland Institute for Emergency Medical Services Systems under subsection (d) of this section may not be used for a criminal investigation or prosecution.    (f)    An emergency medical services provider or a law enforcement officer who in good faith makes a report under this section shall be immune from criminal liability for making the report.
MD. Health - General Code Ann. §  13-3603 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 36 - Reporting of Overdoses|Section 13-3603 - Publication of Overdose Location Prohibited, Exception

    A law enforcement agency may not publicly publish the exact address of an overdose location unless there is a valid public safety concern.
MD. Health - General Code Ann. §  13-3701 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 37 - Community Health Workers|Section 13-3701 - Definitions

    (a)    In this subtitle the following words have the meanings indicated.    (b)    “Advisory Committee” means the State Community Health Worker Advisory Committee.    (c)    “Community health worker” means a frontline public health worker who:        (1)    Is a trusted member of, or has an unusually close understanding of, the community being served;        (2)    Serves as a liaison to, link to, or intermediary between health and social services and the community to:            (i)    Facilitate access to services; and            (ii)    Improve the quality and cultural competence of service delivery; and        (3)    Builds individual and community capacity by increasing health knowledge and self–sufficiency through a range of activities, including:            (i)    Outreach;            (ii)    Community education;            (iii)    The provision of information to support individuals in the community;            (iv)    Social support; and            (v)    Advocacy.    (d)    “Fund” means the State Community Health Workers Fund established under § 13–3707 of this subtitle.
MD. Health - General Code Ann. §  13-3702 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 37 - Community Health Workers|Section 13-3702 - State Community Health Worker Advisory Committee

    (a)    There is a State Community Health Worker Advisory Committee.    (b)    The Advisory Committee consists of the following members:        (1)    The Secretary of Health, or the Secretary’s designee; and        (2)    The following members appointed by the Governor, with the advice and consent of the Senate:            (i)    Nine community health workers;            (ii)    One registered nurse with experience in community health;            (iii)    One licensed social worker with experience in community health;            (iv)    One representative of a community health worker training organization;            (v)    One representative of the Maryland Public Health Association;            (vi)    One representative of a community–based employer of community health workers;            (vii)    One member of the public who is familiar with the services of community health workers;            (viii)    One representative of the Maryland Association of County Health Officers;            (ix)    One representative of the Maryland Hospital Association; and            (x)    One representative of the Community Behavioral Health Association of Maryland.    (c)    Each Advisory Committee member must be a resident of the State.    (d)    (1)    The term of an appointed member is 4 years.        (2)    The terms of the appointed members are staggered as required by the terms provided for the appointed members of the Advisory Committee on October 1, 2018.        (3)    At the end of a term, an appointed member continues to serve until a successor is appointed and qualifies.        (4)    A member who is appointed after a term has begun serves only for the rest of the term and until a successor is appointed and qualifies.        (5)    An appointed member may not serve more than two consecutive full terms.        (6)    To the extent practicable, the Governor shall fill any vacancy on the Advisory Committee within 60 days after the date of the vacancy.    (e)    (1)    The Governor may remove an appointed member for incompetence, misconduct, incapacity, or neglect of duty.        (2)    On the recommendation of the Secretary, the Governor may remove an appointed member whom the Secretary finds to have been absent from two successive Advisory Committee meetings without adequate reason.
MD. Health - General Code Ann. §  13-3703 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 37 - Community Health Workers|Section 13-3703 - Chair; Quorum, Meetings; Reimbursement; Staff; Written Materials; Training or Educational Opportunities

    (a)    (1)    The Secretary of Health, or the Secretary’s designee, shall serve as the chair of the Advisory Committee.        (2)    (i)    From among its appointed members, the Advisory Committee annually shall elect a vice chair and a secretary.            (ii)    The Advisory Committee shall determine:                1.    The manner of election of the vice chair and the secretary; and                2.    The duties of each officer.    (b)    A majority of the members then serving on the Advisory Committee is a quorum.    (c)    The Advisory Committee shall meet at least two times each year, at the times and places that the Advisory Committee determines, to make recommendations regarding the items listed under § 13–3704 of this subtitle.    (d)    A member of the Advisory Committee is entitled to reimbursement for expenses under the Standard State Travel Regulations, as provided in the State budget.    (e)    The Department shall provide staff support and technical assistance for the Advisory Committee.    (f)    Written materials used to conduct the business of the Advisory Committee shall be provided in the preferred language of the Advisory Committee members, as necessary.    (g)    Training or educational opportunities shall be made available to Advisory Committee members on the formal and informal processes that will be used to conduct the business of the Advisory Committee.